Risk of Share Dilution from the Exercise of Stock Acquisition Rights
First written in FY2016. 8 of 9 entries say "Materialised", first in FY2017-Q2. Latest entry: FY2022.
First-corporation moved to the "Worse" side of this theme in 2017, 3 years before the typical company in this theme (2020).
The whole theme swung hardest in 2017: 37 of 68 companies on the "Worse" side.
69 other companies' latest entry also says "Materialised".
- FY2022MaterialisedAnnual report
「1 June 2021–31 August 2021 5,000 13,363,540 1,660 730,429 1,655 689,085 (Note) The increase was attributable to the exercise of stock acquisition rights.」
During the fiscal year, a further 5,000 shares were issued through the exercise of stock acquisition rights, and share dilution occurred in practice. - FY2022-Q1MaterialisedAnnual report
「1 June 2021–31 August 2021 5,000 13,363,540 1,660 730,429 1,655 689,085 (Note) The increase was attributable to the exercise of stock acquisition rights.」
During the cumulative first-quarter period, a further 5,000 shares were issued through the exercise of stock acquisition rights, indicating that dilution has continued to occur in practice. - FY2018MaterialisedAnnual report
「Change in total number of issued shares 43,100」
Between 1 June 2017 and 31 May 2018, a further 43,100 shares were issued through the exercise of stock acquisition rights, indicating that dilution has continued to occur in practice. - FY2018-Q2MaterialisedAnnual report
「The increases in the total number of issued shares, stated capital and capital reserve were attributable to the exercise of stock acquisition rights.」
Between 1 September and 30 November 2017, a further 21,000 shares were issued through the exercise of stock acquisition rights, indicating that dilution has continued to occur in practice. - FY2018-Q1MaterialisedAnnual report
「The increase in common shares from the end of the fiscal year through the filing date was attributable to the exercise of stock acquisition rights.」
During the first quarter, 15,600 shares were added through the exercise of stock acquisition rights, bringing the total number of issued shares as of the filing date to 13,344,040. Dilution has continued to occur in practice. - FY2017MaterialisedAnnual report
「Between 1 June 2017 and 31 July 2017, the total number of issued shares increased by 15,600 through the exercise of stock acquisition rights, while stated capital and the capital reserve each increased by ¥460 thousand.」
A further 15,600 shares were issued through the exercise of stock acquisition rights during the period through the filing date. In addition, 206,400 shares were issued during the fiscal year between 22 December 2016 and 31 May 2017, indicating that dilution has continued to occur in practice. - FY2017-Q3MaterialisedAnnual report
「In addition, the exercise of stock acquisition rights and the resulting issuance of new shares increased stated capital and capital surplus by ¥11.469 million each.」
The issuance of shares following the exercise of stock acquisition rights continued to occur in practice, and the total number of shares issued increased by 202,800 shares during the third quarter accounting period. This has made the risk of dilution of existing shareholders' share value and voting rights more concrete. - FY2017-Q2MaterialisedAnnual report
「The increases in the total number of shares issued, stated capital and capital surplus resulted from requests to exercise stock acquisition rights.」
In the second quarter accounting period, 186,000 shares were issued following requests to exercise stock acquisition rights, meaning that part of the share dilution risk materialized. In addition, new potential shares representing a total of 38,500 shares were issued as the Third and Fourth Series of Stock Acquisition Rights. - FY2016First statedAnnual report
「If these stock acquisition rights are exercised, new shares of the Company will be issued, potentially diluting the value of shares held by existing shareholders and their voting rights.」
The Company identifies dilution of existing shareholders’ share value and voting rights resulting from the exercise of stock options held by directors and employees as a risk.